Département de sociologie, Université de Montréal, Montréal, Québec, Canada.
Can J Psychiatry. 2012 Feb;57(2):93-101. doi: 10.1177/070674371205700206.
To describe trends in the prevalence of prescribed attention-deficit hyperactivity disorder (ADHD) medication by Canadian preschoolers and school-age children and to compare these with trends in the prevalence of the ADHD diagnosis between 1994 and 2007.
Subjects participated in the National Longitudinal Survey on Children and Youth, a Canadian prospective survey collecting data biennially. Three cross-sectional samples of nonreferred children, aged 3 to 9 years and representative of Canadian children for 1994-1995 (n = 12 595), 2000-2001 (n = 13 904), and 2006-2007 (n = 14 655), were selected for the analyses. Information on prescribed medications and ADHD diagnosis was reported by each child's parents. Prevalence was estimated at each cycle, taking the child's age and sex into account.
The estimated prevalence of prescribed medications and ADHD diagnosis in Canada was generally low (less than 3%), but higher for boys (less than 4%) and school-age children (less than 5%). Preschoolers' prevalence of both prescribed medications and ADHD diagnosis stayed stable between 1994 and 2007 (1% or less), while that of school-age children increased nearly 2-fold. Boys' prevalence was higher than that of girls, but girls show the steepest increase over time, up to 2.1-fold. The association between prescribed medications and ADHD diagnosis has strengthened during the 2000s: a greater number of medications were used for children with ADHD (from 43% in 2000 to 59% in 2007) while off-label use of prescribed medications decreased among school-age children.
The upward trend in the prevalence of prescribed ADHD medications and ADHD diagnosis currently observed in contemporary societies is also occurring in Canada, except with preschoolers.
描述加拿大学龄前和学龄儿童中规定的注意力缺陷多动障碍(ADHD)药物的流行趋势,并将这些趋势与 1994 年至 2007 年间 ADHD 诊断的流行趋势进行比较。
受试者参加了加拿大纵向儿童青少年研究,这是一项收集每两年一次数据的前瞻性调查。从非转诊儿童中选择了三个具有代表性的 3 至 9 岁的横断面样本,用于 1994-1995 年(n=12595)、2000-2001 年(n=13904)和 2006-2007 年(n=14655)的分析。每个孩子的父母报告了规定药物和 ADHD 诊断的信息。在每个周期都考虑了孩子的年龄和性别来估计流行率。
加拿大规定药物和 ADHD 诊断的估计流行率通常较低(不到 3%),但男孩(不到 4%)和学龄儿童(不到 5%)较高。1994 年至 2007 年间,学龄前儿童的药物和 ADHD 诊断流行率保持稳定(不到 1%),而学龄儿童的流行率几乎增加了两倍。男孩的流行率高于女孩,但女孩随着时间的推移增长最快,高达 2.1 倍。在 2000 年代,规定药物和 ADHD 诊断之间的关联有所加强:患有 ADHD 的儿童使用的药物数量增加(从 2000 年的 43%增加到 2007 年的 59%),而学龄儿童的处方药物的标签外使用减少。
目前在现代社会中观察到的 ADHD 规定药物和 ADHD 诊断流行率的上升趋势也在加拿大发生,除了学龄前儿童。